MASSDEVICE ON CALL — Israel-based LabStyle Innovations is preparing to launch its iPhone glucometer for the 1st time.
The device is the 1st smartphone-integrated system of its kind to contain both the lancet and test strips, and it communicates wirelessly with an app currently only available for iOS devices. LabStyle plans to commence its "soft launch" in New Zealand and then expand to Italy, Australia and the U.K.
The device maker won CE Mark approval last year to market Dario in the European Union. The device maker said at the time that it hoped to accelerate its FDA 510(k) submission efforts and then focus on regulatory submissions in Asia and South America.
LabStyle’s mobile app is also a stand-alone program that the company plans to offer to users of other glucose monitors. The device maker is also hoping to accelerate its FDA 510(k) submission efforts, after which LabStyle will focus on regulatory submissions in Asia and South America.
The Dario device stores blood glucose readings, keeps track of past readings, predicts glycated hemoglobin and helps monitor dietary activity, according to Medgadget.
Healthcare data a veritable hacker goldmine
Healthcare data represents an easy target with a potentially significant payout for cyber-criminals, according to security experts with Microsoft’s Digital Crimes Unit.
Read more
Smartphone tech assistance for the blind
Samsung’s (LON:BC94) new suite of devices for the blind aim to leverage smartphone technology to help the visually impaired navigate their environments and communicate with others.
Read more
National Rifle Assn. threatens Obama Surgeon General nominee
Dr. Vivek Murphy has previously fought for stricter gun control laws, a history that analysts say endangers his nomination as the next Surgeon General of the U.S.
Read more
Controversy over CT imaging radiation
Society of Cardiovascular Computed Tomography vice president Dr. Jonathan Leipsic challenged concerns about excess radiation exposure, responding to a New York Times editorial by Drs Rita Redberg and Rebecca Smith-Bindman.
Read more